A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias

Clinical trial NCT05521087 · WITHDRAWN

Trial details

NCT number: NCT05521087
Sponsor: Janssen Research & Development, LLC
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Leukemias Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Acute Leukemia of Ambiguous Lineage

Start date: 2025-12-26
Primary completion: 2026-09-11
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.